Importer of Controlled Substances Registration, 45612 [2017-20943]
Download as PDF
<![CDATA[
45612
Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices
Drug Enforcement Administration
Administration as importers of various
classes of schedule I or II controlled
substances.
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on February 27, 2017 (82 FR 11942).
DEPARTMENT OF JUSTICE
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Importer of Controlled Substances
Registration
[FR Doc. 2017–20880 Filed 9–28–17; 8:45 am]
ACTION:
BILLING CODE P
SUMMARY:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Company
FR docket
United States Pharmacopeial.
Convention .................................................................................
AMRI Rensselaer, Inc ................................................................
R & D Systems, Inc ...................................................................
Sigma-Aldrich International.
GMBH ........................................................................................
Cambrex High Point, Inc ...........................................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: September 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–20943 Filed 9–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cody Laboratories, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
VerDate Sep<11>2014
18:50 Sep 28, 2017
Jkt 241001
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
82 FR 34694 ............................................................................
82 FR 34696 ............................................................................
82 FR 35546 ............................................................................
July 26, 2017.
July 26, 2017.
July 31, 2017.
82 FR 35547 ............................................................................
82 FR 35992 ............................................................................
July 31, 2017.
August 2, 2017.
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 30, 2017. Such
persons may also file a written request
for a hearing on the application on or
before October 30, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
PO 00000
Frm 00038
Published
Fmt 4703
Sfmt 9990
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
16, 2017, Cody Laboratories, Inc., Steve
Hartman, 601 Yellowstone Avenue,
Cody, Wyoming 82414–9321 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Phenylacetone ..............
Poppy Straw Concentrate.
Tapentadol ....................
Drug
code
Schedule
8501
9670
II
II
9780
II
The company plans to import narcotic
raw materials to manufacture bulk
controlled substances for distribution to
its customers. The company plans to
import an intermediate form of
tapentadol (9870), to bulk manufacture
tapentadol for distribution to its
customers.
Dated: September 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–20942 Filed 9–28–17; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 82, Number 188 (Friday, September 29, 2017)]
[Notices]
[Page 45612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20943]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration as importers of
various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
United States Pharmacopeial.
Convention.................. 82 FR 34694......... July 26, 2017.
AMRI Rensselaer, Inc........ 82 FR 34696......... July 26, 2017.
R & D Systems, Inc.......... 82 FR 35546......... July 31, 2017.
Sigma-Aldrich International.
GMBH........................ 82 FR 35547......... July 31, 2017.
Cambrex High Point, Inc..... 82 FR 35992......... August 2, 2017.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrants to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed persons.
Dated: September 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-20943 Filed 9-28-17; 8:45 am]
BILLING CODE 4410-09-P
